JUSTINE M KING, MS, CCC-SLP
Speech Language Pathology at 75 St, New York, NY

License number
New York 015563
Category
Speech Language Pathology
Type
Speech-Language Pathologist
Address
Address
444 E 75Th St APT 7C, New York, NY 10021
Phone
(212) 249-0416

Personal information

See more information about JUSTINE M KING at radaris.com
Name
Address
Phone
Justine King, age 41
415 Pullman Ave, Rochester, NY 14615
(585) 281-7100
Justine King, age 55
444 E 75Th St APT 7C, New York, NY 10021
(212) 249-0416
Justine King
444 E 75Th St, New York, NY 10021
(212) 249-0416
Justine King
5841 S Salina St APT 3, Syracuse, NY 13205
Justine King
200 River St, Rochester, NY 14612
(585) 287-5132

Professional information

Justine King Photo 1

Speech Language Pathologist: Private Practice

Position:
Speech Language Pathologist: Independent Contractor at NYS Bureau of Early Intervention, Speech Language Pathologist at Private Practice
Location:
Greater New York City Area
Industry:
Individual & Family Services
Work:
NYS Bureau of Early Intervention since Nov 2005 - Speech Language Pathologist: Independent Contractor Private Practice since Apr 2005 - Speech Language Pathologist Riverdale Early Childhood Center Jul 2004 - Jun 2005 - Speech Language Pathologist
Education:
Columbia University in the City of New York 2002 - 2004
M.S., Speech Language Pathology
University of Notre Dame 1986 - 1990
B.A., Philosophy
Skills:
Early Intervention, Apraxia, Phonological Disorders, Motor Speech Disorders, Prompt, Language Disorders, Cognition, Aphasia
Honor & Awards:
multiple ASHA ACE Awards


Justine M King Photo 2

Justine M King, New York NY - MS (Mitral stenosis; also Master of Science or Medical scientist)

Specialties:
Speech-Language Pathology
Address:
444 E 75Th St SUITE 7C, New York 10021
(212) 249-0416 (Phone)
Languages:
English


Justine King Photo 3

Justine King

Location:
Greater New York City Area
Industry:
Pharmaceuticals
Skills:
Regulatory Affairs, Regulatory Submissions, Sop, FDA, CMC, Lifesciences, IND, eCTD, Pharmaceutical Industry, Clinical Development, Regulatory Filings, Change Control, Regulatory Requirements, NDA, Regulatory Guidelines, Regulatory Policy, Regulatory Agencies, OTC, PhRMA Code, Pharmaceutical Law, Pharmaceutical Sales, Pharmacists, Prescription Drugs